IRIS UniCatt

Bosello, Silvia Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.351
AS - Asia 4.600
EU - Europa 4.105
SA - Sud America 801
AF - Africa 120
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.183
SG - Singapore 2.141
CN - Cina 1.153
DE - Germania 1.143
IT - Italia 740
BR - Brasile 674
SE - Svezia 530
FR - Francia 481
VN - Vietnam 337
UA - Ucraina 242
IN - India 219
GB - Regno Unito 199
IE - Irlanda 182
FI - Finlandia 152
ID - Indonesia 145
PL - Polonia 115
JP - Giappone 99
RU - Federazione Russa 95
CA - Canada 85
HK - Hong Kong 85
TR - Turchia 76
KR - Corea 58
AR - Argentina 51
BD - Bangladesh 50
MX - Messico 50
IQ - Iraq 46
BE - Belgio 43
ZA - Sudafrica 35
NL - Olanda 31
PK - Pakistan 31
AT - Austria 30
ES - Italia 25
IR - Iran 22
MA - Marocco 22
SA - Arabia Saudita 21
VE - Venezuela 20
UZ - Uzbekistan 19
AU - Australia 18
CO - Colombia 16
EC - Ecuador 15
LT - Lituania 15
CI - Costa d'Avorio 13
JO - Giordania 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
TN - Tunisia 11
CZ - Repubblica Ceca 10
PT - Portogallo 10
RO - Romania 10
PH - Filippine 9
AZ - Azerbaigian 8
CL - Cile 8
MY - Malesia 8
JM - Giamaica 7
DK - Danimarca 6
EG - Egitto 6
EU - Europa 6
IL - Israele 6
TW - Taiwan 6
BG - Bulgaria 5
CH - Svizzera 5
CR - Costa Rica 5
HU - Ungheria 5
KG - Kirghizistan 5
PE - Perù 5
TT - Trinidad e Tobago 5
AL - Albania 4
ET - Etiopia 4
GR - Grecia 4
HN - Honduras 4
KW - Kuwait 4
NG - Nigeria 4
NP - Nepal 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CG - Congo 3
DZ - Algeria 3
LB - Libano 3
MD - Moldavia 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
TH - Thailandia 3
BB - Barbados 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
KH - Cambogia 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
SI - Slovenia 2
TJ - Tagikistan 2
VA - Santa Sede (Città del Vaticano) 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 14.980
Salva come PNG Salva come JPEG
Città #
Singapore 1.234
Ashburn 591
Chandler 591
San Jose 591
Beijing 187
Dublin 181
Rome 178
Ann Arbor 173
Hefei 169
New York 150
Los Angeles 135
Jacksonville 134
Jakarta 129
Dearborn 121
Ho Chi Minh City 119
Lauterbourg 119
The Dalles 108
Munich 107
Milan 98
San Mateo 96
Tokyo 92
Houston 89
Wilmington 88
Nanjing 84
Woodbridge 84
Helsinki 80
Hanoi 79
Frankfurt am Main 78
Seattle 76
Hong Kong 72
Boston 65
Kraków 64
Fairfield 61
Dallas 59
Moscow 59
São Paulo 59
Seoul 56
Kent 53
Nürnberg 48
Chicago 47
Marseille 43
Santa Clara 43
Brussels 42
Lawrence 42
Izmir 40
Nuremberg 40
Buffalo 39
Paris 38
Cattolica 37
Bremen 34
Nanchang 34
Orem 33
Warsaw 33
Pune 32
Düsseldorf 29
Brooklyn 28
Redwood City 28
Atlanta 26
Chennai 26
Guangzhou 25
Princeton 25
Shanghai 25
London 24
Montreal 24
St Louis 24
Hebei 23
Johannesburg 23
Norwalk 23
Tianjin 23
Kunming 21
Toronto 21
Boardman 20
Hyderabad 20
Rio de Janeiro 20
Stockholm 20
Baghdad 19
Da Nang 19
Phoenix 19
Lancaster 18
Mexico City 18
Belo Horizonte 17
Tashkent 17
Augusta 16
Leawood 16
Manchester 16
North Bergen 16
San Francisco 16
Trieste 16
Turku 16
Cambridge 15
Denver 15
Falls Church 15
Fremont 15
Florence 14
Hangzhou 14
Abidjan 13
Amman 13
Andover 13
Detroit 13
Mumbai 13
Totale 8.024
Salva come PNG Salva come JPEG
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 356
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 315
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 310
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 264
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 244
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 228
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 224
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 209
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 209
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 196
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 195
Assessment of neurological manifestations in hospitalized patients with COVID-19 195
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 191
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 182
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 181
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 180
Adult-onset Still's disease following COVID-19 vaccination 175
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 170
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 168
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 167
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 165
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 165
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 163
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 163
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 161
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 160
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 158
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 156
Sarilumab use in severe SARS-CoV-2 pneumonia 156
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 155
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 147
A Comprehensive Natural Language Processing Pipeline for the Chronic Lupus Disease 144
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 144
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 142
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 140
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 139
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 138
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 137
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 135
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 133
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 132
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 132
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 129
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 126
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 126
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 122
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 121
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 119
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 118
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 118
An unusual lung involvement in scleroderma: lipoid pneumonia 118
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 117
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 115
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 114
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 112
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 110
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 110
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 110
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 109
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression 109
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 108
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 108
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 107
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 106
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 105
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 105
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 104
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 104
Troponin in Stable Ischemic Heart Disease and Diabetes 102
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 101
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 99
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 98
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 98
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 98
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 97
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 95
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 93
Troponin in Stable Ischemic Heart Disease and Diabetes 92
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 91
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 90
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 90
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 88
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 83
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 83
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 83
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 83
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry 81
Understanding Attitudes Toward Zoster Vaccination in the Hospital Setting: A Multidisciplinary Model to Contrast Vaccine Hesitancy in Fragile Patients—A Prospective Longitudinal Observational Study 81
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 79
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 78
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 78
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 76
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 76
Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome 74
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 74
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 73
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 73
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 73
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 72
Totale 13.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 0 107 17
2021/2022800 54 38 23 56 61 44 36 102 39 86 106 155
2022/20231.685 214 235 127 271 83 191 83 138 152 14 56 121
2023/20241.067 36 278 53 57 38 146 73 76 21 31 149 109
2024/20252.587 49 51 218 85 255 114 111 108 355 271 550 420
2025/20266.097 898 211 390 725 1.248 372 1.112 330 366 397 48 0
Totale 15.224